ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,131, issued on June 17, was assigned to NAVI BIO-THERAPEUTICS INC. (Kaohsiung, Taiwan).
"Personalized cancer immunotherapy" was invented by Bor-Yu Tsai (New Taipei, Taiwan), Kuang-Yu Chen (Kaohsiung, Taiwan), Shin-Tsung Huang (Taipei, Taiwan) and Wei-Ting Hsu (Taipei, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method for obtaining an antibody or antigen-binding fragment thereof that specifically binds to and against a tumor sample, comprising: administering autologous dendritic cells to a subject; taking immune cells and a tumor sample from the subject; constructing an antibody library of the immune cel...